AgomAb Therapeutics NV · NASDAQ:AGMB
Epstein David R bought 14,980 AgomAb Therapeutics NV shares (Form 4)
Traded Nov 13, 2026 · Filed Nov 16, 2026
On Nov 13, 2026, Epstein David R (Director) bought 14,980 AgomAb Therapeutics NV shares at an average US$5.92 for US$88,679, leaving 54,980 shares. Filed Nov 16, 2026 (Form 4).
- Bought
- 14,980 shares
- Price
- US$5.92 average (US$5.75 to US$6.02)
- Value
- US$88,679
- Holding after
- 54,980 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 13, 2026 | Common shares | Buy | 5,000 | US$5.99 | 45,000 | Direct |
| Nov 13, 2026 | Common shares | Buy | 20 | US$6.00 | 45,020 | Direct |
| Nov 13, 2026 | Common shares | Buy | 5,000 | US$5.75 | 50,020 | Direct |
| Nov 13, 2026 | Common shares | Buy | 4,960 | US$6.02 | 54,980 | Direct |
Source
Download original · View original at SEC